Model | R2Nagelkerke = 0.15 | R2Nagelkerke = 0.5 | R2Nagelkerke = 0.8 | |||
---|---|---|---|---|---|---|
Sample size | EPP | Sample size | EPP | Sample size | EPP | |
NB 5-year mortality risk | 2383 | 24.39 | 666 | 6.82 | 550 | 5.63 |
NB relapse/progression risk | 2495 | 21.42 | 704 | 6.04 | 590 | 5.06 |
NB time to death | 2951 | 14.79 | 858 | 4.30 | 749 | 3.75 |
HR-NB 5-year mortality risk | 2247 | 37.45 | 620 | 10.33 | 501 | 8.35 |
HR-NB 5-year relapse/progression risk | 2280 | 31.01 | 631 | 8.58 | 513 | 6.98 |
HR-NB time to relapse/progression | 2280 | 24.15 | 631 | 6.68 | 513 | 5.43 |
DIPG 1-year mortality risk | 2247 | 33.70 | 620 | 9.30 | 501 | 7.52 |
DIPG 2-year mortality risk | 2848 | 16.04 | 824 | 4.64 | 713 | 4.02 |
DIPG 1-year progression risk | 2575 | 20.17 | 731 | 5.73 | 618 | 4.84 |
DIPG time to death | 2705 | 16.72 | 775 | 4.79 | 663 | 4.10 |
DIPG time to progression | 2419 | 20.69 | 679 | 5.81 | 563 | 4.82 |